资讯

Everyday Health on MSN5 天
Wegovy May Halt and Even Reverse Severe Liver Disease
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
News-Medical.Net on MSN2 天
Semaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial shows
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Wegovy treated a serious form of liver disease in a major clinical trial
Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...
Sitting Is The New Smoking- For Your Liver Too
Liver disease usually develops stealthily, but the harm could be fatal if left unchecked. On this Liver Day, let us realize ...
Healio6 天
Semaglutide tied to significant improvements in MASH, liver fibrosis at 72 weeks
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
Applied Clinical Trials Online5 天
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...